Noopept,促智和神经保护药
Noopept
N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯(Noopept);Noopept(GVS-111) 抑制剂;苯乙酰甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯生产厂家 N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯(Noopept);Noopept(GVS-111) 抑制剂;苯乙酰甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯生产厂家 展开
157115-85-0
C₁₇H₂₂N₂O₄
318.37
中文名称 Noopept,促智和神经保护药
中文别名 N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯(Noopept);Noopept(GVS-111) 抑制剂;苯乙酰甘氨酸乙酯;N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯生产厂家
英文名称 Noopept
英文别名 Noopept;(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate;ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate;N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester;1-(2-Phenylacetyl)-L;1-(2-Phenylacetyl)-L-prolylglycine Ethyl Ester;N-Phenylacetyl-L-prolylglycine ethyl ester;GVS111;GVS-111;Omberacetam;SGS 111;SGS-111;NOOPEPT(GVS-111);1-(2-Phenylacetyl)-L-prolyl-glycine ethyl ester;Ethyl N-[1-(Phenylacetyl)-L-prolyl]glycinate;N-[1-(Phenylacetyl)-L-prolyl]glycine Ethyl Ester;skype;Noopept,N-Phenylacetyl-L-Prolylglycine ethyl ester;ethyl (2-phenylacetyl)-L-prolylglycinate;J759.455K;NS00017406;CS-1575;Glycine, N-(1-(phenylacetyl)-L-prolyl)-, ethyl ester;CHEMBL4303687;N1120;ethyl phenylacetyl-Pro-Gly;OMBERACETAM [INN];Noopept, >=98% (HPLC);GVS 111;DVD-111;Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester;Q7049784;UNII-4QBJ98683M;DTXSID80166214;SCHEMBL194807;NCGC00378939-05;Omberacetam [WHO-DD];ethyl 2-{[(2S)-1-(2-phenylacetyl)pyrrolidin-2-yl]formamido}acetate;C72975;157115-85-0;AS-10555;ethyl 1-(phenylacetyl)-L-prolylglycinate;4QBJ98683M;AM84514;HY-17456;AKOS016012268;Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester;n-phenylacetyl-l-prolylglycine ethyl ester;DB-371006;1-(2-phenylacetyl)-l-prolylglycine ethyl ester;GLXC-04495;BRD-K22520627-001-01-7
CAS No. 157115-85-0
分子式 C₁₇H₂₂N₂O₄
分子量 318.37
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS